Santo, G., Di Santo, G., Sviridenko, A., Bayerschmidt, S., Wirth, L., Scherbauer, F., . . . Virgolini, I. (2024). Efficacy and safety of rechallenge with [177Lu]Lu-PSMA-I&T radioligand therapy in metastatic castration resistant prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging, 52(1), 354-365. https://doi.org/10.1007/s00259-024-06905-5
Chicago-referens (17:e uppl.)Santo, Giulia, et al. "Efficacy and Safety of Rechallenge with [177Lu]Lu-PSMA-I&T Radioligand Therapy in Metastatic Castration Resistant Prostate Cancer." European Journal of Nuclear Medicine and Molecular Imaging 52, no. 1 (2024): 354-365. https://doi.org/10.1007/s00259-024-06905-5.
MLA-referens (9:e uppl.)Santo, Giulia, et al. "Efficacy and Safety of Rechallenge with [177Lu]Lu-PSMA-I&T Radioligand Therapy in Metastatic Castration Resistant Prostate Cancer." European Journal of Nuclear Medicine and Molecular Imaging, vol. 52, no. 1, 2024, pp. 354-365, https://doi.org/10.1007/s00259-024-06905-5.
